Clinical trial
Effects of Transdermal Scopolamine on Occupational Performance
NCT00374478 · Boston University, Other · Completed
Key facts
| NCT number | NCT00374478 |
|---|---|
| Title | Effects of Transdermal Scopolamine on Occupational Performance |
| Official title | Effects of Transdermal Scopolamine on Occupational Performance |
| Lead sponsor | Boston University, Other |
| Collaborators | Centers for Disease Control and Prevention U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Motion Sickness |
| Intervention type | Drug |
| Interventions | Scopolamine |
| Enrollment | 33 |
| Start date | Apr 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Sep 11, 2006 |
| Last update posted | Apr 9, 2007 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: